The vultures are circling.Reuters-http://www.reuters.com/article/2011/11/14/us-mfglobal-lawyers-idUSTRE7AD1PE20111114
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%